Tvardi Therapeutics, Inc. (TVRD)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-87.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $7.14M | $20.97M | $41.87M | $23.03M | $135.08M | $19.89M | $13.47M | $911.0K | $86.0K |
| Cost of Revenue | — | — | — | — | $0 | — | — | — | — | — |
| Operating Income | -$26.75M | -$28.11M | -$121.50M | -$87.53M | -$89.08M | $5.38M | -$111.68M | -$77.38M | -$59.48M | -$58.40M |
| Net Income | -$18.21M | -$29.40M | -$118.51M | -$85.47M | -$88.44M | $8.41M | -$106.37M | -$74.01M | -$58.12M | -$57.28M |
| EPS (Diluted) | $-3.26 | $-11.42 | $-26.26 | $-19.12 | $-1.74 | $0.18 | $-2.49 | $-2.06 | — | — |
| Total Assets | $32.07M | $35.20M | $125.84M | $182.24M | $247.06M | $271.16M | $232.96M | $190.82M | $97.00M | $63.83M |
| Total Liabilities | $11.13M | $40.83M | $68.76M | $23.46M | — | — | — | — | — | — |
| Shareholders' Equity | $20.95M | -$91.13M | -$62.06M | $158.78M | $227.52M | $249.00M | $186.71M | $133.63M | $86.78M | $50.73M |
| Cash & Equivalents | $20.73M | $31.61M | $51.77M | $63.74M | $13.45M | $31.68M | $18.30M | $15.08M | $9.39M | $12.09M |
| Operating Cash Flow | -$23.50M | -$18.30M | -$92.08M | -$78.73M | -$60.09M | -$5.49M | -$109.22M | -$22.30M | -$54.83M | -$47.38M |
| Capital Expenditures | — | $1.05M | $2.38M | $43.0K | $39.0K | $349.0K | $18.0K | $73.0K | $58.0K | $717.0K |
| Shares Outstanding | 7.78M | 2.57M | 4.51M | 4.47M | 50.72M | 47.92M | 42.67M | 35.89M | 31.20M | 27.28M |
| Dividends Per Share | $0.00 | — | — | — | — | — | — | — | — | — |